NewsMV
← News·Markets · OutlookMarkets

AbbVie Eyes $10.9 Billion Biotech Acquisition to Add Experimental Eczema Drug

AbbVie is reportedly pursuing the acquisition of a biotech company for $10.9 billion in cash, with the deal centered on an experimental atopic dermatitis treatment, according to a Financial Times report. The…

NM
NewsMV Markets Desk
3 min read
20 June 2026Markets desk
Share this dispatch
Categorymarkets

Filed via marketwatch.com

← Back to all dispatchesFront page →
Keep reading

More from the markets desk

Markets · Digital AssetsMarkets

Intesa Sanpaolo triples staked Ether ETF position to $7.1 million, trims IBIT and Bitcoin ETF holdings

$ETH is in focus after Intesa Sanpaolo, Italy's largest bank, tripled its staked Ether ETF holdings to $7.1 million while cutting shares in two spot Bitcoin ETFs, including IBIT. The repositioning shifts the bank's…

NM
NewsMV Markets Desk
3 min read
MarketsMarkets

Shark ChillPill personal cooling system hits $99.99 at Amazon, matching all-time low

Shark's ChillPill Personal Fan and Cooling System is at $99.99 on Amazon, a $30 cut from its $129.99 list price and a match for the product's all-time low. The device combines a rechargeable fan with a dry-touch…

NM
NewsMV Markets Desk
3 min read
MarketsMarkets

BELFB sets $0.07 quarterly cash dividend, ex-date October 15

In focus for BELFB shareholders: the company has declared a quarterly cash dividend of $0.07 per share in cash, with both the ex-dividend date and the record date set for October 15, 2026. The payment date is Octob

NM
NewsMV Markets Desk
3 min read